Yoshimi Imura

1.2k citations

31 papers · 1.0k indexed · h-index 16

Impact in

Cardiology and Cardiovascular Medicine top 10%
- Renin-Angiotensin System Studies
- Blood Pressure and Hypertension Studies
Biochemistry top 10%

Papers in ⓘ

Cardiology and Cardiovascular Medicine 14
- Renin-Angiotensin System Studies 7
- Antiplatelet Therapy and Cardiovascular Diseases 7
Molecular Biology 10
- Plant biochemistry and biosynthesis 3

Co-authors: Kohei Nishikawa (13 shared papers)Zen‐ichi Terashita (14 shared papers)Yasuo Sugiyama (5 shared papers)Ryuichi Tozawa (3 shared papers)Tomoyuki Nishimoto (3 shared papers)Yuichiro Amano (3 shared papers)Yumiko Shibouta (8 shared papers)Mami Ojima (1 shared paper)
Journals: European Journal of Pharmacology (3 papers)Biochemical Pharmacology (2 papers)Thrombosis Research (2 papers)Life Sciences (2 papers)Kidney International (2 papers)
Partner nations: Japan United States Belgium

In The Last Decade

Yoshimi Imura

30 papers receiving 961 citations

Peers

Countries citing papers authored by Yoshimi Imura

Since Specialization

Citations

This map shows the geographic impact of Yoshimi Imura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshimi Imura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshimi Imura more than expected).

Fields of papers citing papers by Yoshimi Imura

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshimi Imura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshimi Imura. The network helps show where Yoshimi Imura may publish in the future.

Co-authors

The 25 scholars most cited alongside Yoshimi Imura, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Yoshimi Imura Line = papers co-authored together Yoshimi Imura links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 31 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Is platelet activating factor (PAF) a mediator of endotoxin shock? European Journal of Pharmacology ·Zen‐ichi Terashita, Yoshimi Imura, Kohei Nishikawa, S. Sumida	1985	203
2	In Vitro Antagonistic Properties of a New Angiotensin Type 1 Receptor Blocker, Azilsartan, in Receptor Binding and Function Studies Journal of Pharmacology and Experimental Therapeutics ·Mami Ojima, Hideki Igata, Masayuki Tanaka, Hiroki Sakamoto, Takanobu Kuroita, Yasuhisa Kohara, Keiji Kubo, Hiromitsu Fuse, Yoshimi Imura, Keiji Kusumoto, Hideaki Nagaya	2010	122
3	Identification of Benzoxazin-3-one Derivatives as Novel, Potent, and Selective Nonsteroidal Mineralocorticoid Receptor Antagonists Journal of Medicinal Chemistry ·Tomoaki Hasui, Nobuyuki Matsunaga, Taiichi Ora, Norio Ohyabu, Nobuhiro Nishigaki, Yoshimi Imura, Yumiko Igata, Hideki Matsui, Takashi Motoyaji, Toshimasa Tanaka, Noriyuki Habuka, Satoshi Sogabe, Midori Ono, Christopher S. Siedem, Tony P. Tang, Cassandra Gauthier, Lisa A. De Meese, Steven A. Boyd, Shoji Fukumoto	2011	90
4	Inhibition by CV-3988 of the binding of [3H]-platelet activating factor (PAF) to the platelet Biochemical Pharmacology ·Zen‐ichi Terashita, Yoshimi Imura, Kohei Nishikawa	1985	87
5	Comparing myotoxic effects of squalene synthase inhibitor, T-91485, and 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors in human myocytes Biochemical Pharmacology ·Tomoyuki Nishimoto, Ryuichi Tozawa, Yuichiro Amano, Takeo Wada, Yoshimi Imura, Yasuo Sugiyama	2003	64
6	Lipid‐lowering properties of TAK‐475, a squalene synthase inhibitor, in vivo and in vitro British Journal of Pharmacology ·Tomoyuki Nishimoto, Yuichiro Amano, Ryuichi Tozawa, Eiichiro Ishikawa, Yoshimi Imura, Hidefumi Yukimasa, Yasuo Sugiyama	2003	59
7	Effect of candesartan cilexetil (TCV-116) in rats with chronic renal failure Kidney International ·Masakuni Noda, Takanori Matsuo, Ryo Fukuda, M Ohta, Hiroko Nagano, Yumiko Shibouta, Takehiko Naka, Kohei Nishikawa, Yoshimi Imura	1999	43
8	Comparison of the effects of pioglitazone and rosiglitazone on macrophage foam cell formation Biochemical and Biophysical Research Communications ·Masao Hirakata, Ryuichi Tozawa, Yoshimi Imura, Yasuo Sugiyama	2004	43
9	Possible role of platelet activating factor (PAF) in disseminated intravascular coagulation (DIC), evidenced by use of a PAF antagonist, CV-3988 Life Sciences ·Yoshimi Imura, Zen‐ichi Terashita, Kohei Nishikawa	1986	42
10	Lipid-lowering effects of TAK-475, a squalene synthase inhibitor, in animal models of familial hypercholesterolemia European Journal of Pharmacology ·Yuichiro Amano, Tomoyuki Nishimoto, Ryu-ichi Tozawa, Eiichiro Ishikawa, Yoshimi Imura, Yasuo Sugiyama	2003	36
11	Inhibition of Angiotensin Converting Enzyme by CV-3317, a Non-Sulfhydryl Compound The Japanese Journal of Pharmacology ·Yoshiyuki Inada, Zen‐ichi Terashita, Yoshimi Imura, Masao J. Tanabe, Kohei Nishikawa, Shintaro Kikuchi	1986	30
12	Endothelin-induced sudden death and the possible involvement of platelet activating factor (PAF) Life Sciences ·Zen‐ichi Terashita, Yumiko Shibouta, Yoshimi Imura, Kuniko Iwasaki, Kohei Nishikawa	1989	24
13	Involvement of Angiotensin II in Progression of Renal Injury in Rats With Genetic Non-insulin-Dependent Diabetes Mellitus (Wistar Fatty Rats) The Japanese Journal of Pharmacology ·Masakuni Noda, Takanori Matsuo, Hiroko Nagano-Tsuge, M Ohta, Masahiro Sekiguchi, Yumiko Shibouta, Takehiko Naka, Yoshimi Imura	2001	22
14	The thromboxane A2/prostaglandin endoperoxide receptor antagonist activity of CV-4151, a thromboxane A2 synthetase inhibitor European Journal of Pharmacology ·Yoshimi Imura, Zen-ichi Tereshita, Yumiko Shibouta, Kohei Nishikawa	1988	21
15	Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats Kidney International ·Yumiko Shibouta, Zen‐ichi Terashita, Yoshimi Imura, Akio Shino, Masaki Kawamura, Kayoko Ohtsuki, Shigenori Ohkawa, Kohei Nishikawa, Yoshihiro Fujiwara	1991	20
16	Synergistic Antithrombotic Properties of G4120, a RGD-Containing Synthetic Peptide, and Argatroban, a Synthetic Thrombin Inhibitor, in a Hamster Femoral Vein Platelet-Rich Thrombosis Model Thrombosis and Haemostasis ·Yoshimi Imura, Jean–Marie Stassen, Ingrid Vreys, Emmanuel Lesaffre, Herman K. Gold, D Collen	1992	19
17	Antagonistic action of AA-2414 on thromboxane A2/prostaglandin endoperoxide receptor in platelets and blood vessels. The Japanese Journal of Pharmacology ·Yoshimi Imura, Zen‐ichi Terashita, Yumiko Shibouta, Yoshiyuki Inada, Kohei Nishikawa	1990	14
18	TAK-442, a Direct Factor Xa Inhibitor, Inhibits Monocyte Chemoattractant Protein 1 Production in Endothelial Cells via Involvement of Protease-Activated Receptor 1 Frontiers in Pharmacology ·Emiko Shinozawa, Masaaki Nakayama, Yoshimi Imura	2018	11
19	Effects of thromboxane A2 synthase inhibitors (CV-4151 and ozagrel), aspirin, and ticlopidine on the thrombosis caused by endothelial cell injury Thrombosis Research ·Zen-ichi Terashita, Yoshimi Imura, Masaki Kawamura, Kaneyoshi Kato, Kohei Nishikawa	1995	11
20	Platelet activating factor (PAF) antagonists: synthesis and structure-activity studies of novel PAF analogs modified in the phosphorylcholine moiety Journal of Medicinal Chemistry ·Muneo Takatani, YOSHIO YOSHIOKA, Akihiro Tasaka, Zen‐ichi Terashita, Yoshimi Imura, Kohei Nishikawa, Susumu Tsushima	1989	11

About Yoshimi Imura

Yoshimi Imura is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology, Pharmacology, Physiology and Biochemistry, having authored 31 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renin-Angiotensin System Studies (7 papers), Antiplatelet Therapy and Cardiovascular Diseases (7 papers), Inflammatory mediators and NSAID effects (7 papers), Eicosanoids and Hypertension Pharmacology (5 papers), Hormonal Regulation and Hypertension (4 papers), Nitric Oxide and Endothelin Effects (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers) and Plant biochemistry and biosynthesis (3 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (246 citations), Biochemistry (78 citations), Endocrinology, Diabetes and Metabolism (162 citations), Hematology (79 citations) and Pharmacology (117 citations). Yoshimi Imura has collaborated with scholars based in Japan, United States and Belgium. Frequent co-authors include Kohei Nishikawa, Zen‐ichi Terashita, Yasuo Sugiyama, Ryuichi Tozawa, Tomoyuki Nishimoto, Yuichiro Amano, Yumiko Shibouta, Mami Ojima, Takanobu Kuroita and Hiroki Sakamoto. Their work appears in journals such as European Journal of Pharmacology, Biochemical Pharmacology, Thrombosis Research, Life Sciences and Kidney International.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact